NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead. Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year. Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet. That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict. |
Highlights of Asian Cup 2022Company Law draft revision to bolster confidenceXi Story: A Champion of Closer PeopleChina's goal of engaging 300 million people in winter sports achieved: surveyClean energy key to CO2 goalsChina's Deep Sea No 1 gas field completes natural gas condensate tank cleaning and inspectionCompany Law draft revision to bolster confidenceCounting down to Chengdu Universiade: venues with Sichuan flavorDecade after divorce, woman finds new life on two wheelsChina wins 2023 FIBA 3x3 Women's Series in Wuhan